Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Secukinumab
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Secukinumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir
Generic Name: secukinumab
Brand name: Cosentyx, Cosentyx Sensoready Pen
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Secukinumab Subcutaneous
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Secura Antifungal
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Secura Antifungal Extra Thick
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Secura Antifungal Topical
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Seebri
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Seebri Neohaler
- Secukinumab-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Secukinumab-Omeclamox-Pak
- Secukinumab-Omega-3 Fatty Acid Capsules
- Secukinumab-Omega-3 Fatty Acids
- Secukinumab-Omega-3 polyunsaturated fatty acids
- Secukinumab-Omega-3-acid ethyl esters